{"url_path":"/sec/tgtx/10-k/2026/item-1b","section_key":"item-1b","section_title":"Item 1B UNRESOLVED STAFF COMMENTS**","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-02-27","source_url":"https://www.sec.gov/Archives/edgar/data/1001316/0001437749-26-006133-index.html","accession_number":"0001437749-26-006133","cik":"0001001316","ticker":"TGTX","issuer_name":"TG THERAPEUTICS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1001316/0001437749-26-006133-index.html","primary_entity_key":"0001001316","primary_entity_name":"TG THERAPEUTICS, INC."},"word_count":8,"has_tables":true,"body_markdown":"**ITEM 1B. UNRESOLVED STAFF COMMENTS**\n\n ​\n\nNone.\n\n ​"}